FDA Drug Application (203629) for NEOSTIGMINE METHYLSULFATE by FRESENIUS KABI USA

Back to FDA Applications sponsored by FRESENIUS KABI USA

Application Number203629
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage5MG/10ML (0.5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEOSTIGMINE METHYLSULFATE
Active IngredientNEOSTIGMINE METHYLSULFATE

Active IngredientCount
List of drugs with Active Ingredient NEOSTIGMINE METHYLSULFATE2


Back to FDA Applications sponsored by FRESENIUS KABI USA